Commentary: baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the examine trial
The paper analyses the plasma levels of adiponectin in acute coronary syndrome type 2 diabetes patients enrolled in the study EXAMINE where they were monitored for CV outcomes for a period of 18 months. In the introduction and the discussion, the authors mention that the relation between the adiponectin level and CV outcomes has been →